Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: A Study of RO5310074 in Patients With Psoriatic Arthritis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for RO5310074 in patients with psoriatic arthritis; the Phase 1 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RO5310074

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Arthritis, Psoriatic | Phase 1 | Status: COMPLETED